Ind Swift Laboratories Current Share Price | Ind Swift Laboratories Stock Screener
INDSWFTLAB
Pharmaceuticals
Ind Swift Laboratories Current Stock Price Today
Live Share Price NSE
₹373.25
▼
-5.00 (-1.32%)
Live Share Price BSE
₹373.10
▼
-4.70 (-1.24%)
As of September 18, 2026, the live Ind Swift Laboratories share price (NSE: INDSWFTLAB) is ₹373.25 on NSE and ₹373.10 on BSE, down 1.32% from the previous close, with shares trading between ₹368.00 and ₹385.15 in today's trading session, and a 52-week range of ₹88.15–₹388.55.
Browse INDSWFTLAB complete financial statements to support your investment research.
Use the Ind Swift Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Ind Swift Laboratories Market Cap
₹3,346.25 Cr.
INDSWFTLAB P/E Ratio (TTM)
57.28
Ind Swift Laboratories P/B Ratio
2.37
EPS (TTM)
₹4.95
Dividend Yield
-
Debt to Equity
0.02
INDSWFTLAB 52 Week High
₹388.55
Ind Swift Laboratories 52 Week Low
₹88.15
Operating Margin
9.00%
Profit Margin
8.72%
INDSWFTLAB Revenue (TTM)
₹172.00
EBITDA
₹18.00
Net Income
₹15.00
Total Assets
₹1,673.00
Total Equity
₹1,384.00
Ind Swift Laboratories Current Share Price Chart
Track the current Ind Swift Laboratories share price and stock price with an interactive chart. Analyse INDSWFTLAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete Ind Swift Laboratories stock quote in one place.
Ind Swift Laboratories Company Profile - Fundamental Screener
Screen Ind Swift Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDSWFTLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE915B01019
Ind Swift Laboratories Balance Sheet Screener
Screen INDSWFTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,673 | 1,438 | 1,165 | 1,824 | 1,801 | 1,818 | 1,870 | 1,924 | 2,023 | 2,138 |
| Current Assets | 977 | 865 | 661 | 1,165 | 1,075 | 944 | 863 | 836 | 842 | 832 |
| Fixed Assets | 316 | 273 | 8 | 588 | 630 | 753 | 843 | 914 | 934 | 1,042 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 32 | 45 | 12 | 771 | 866 | 901 | 906 | 980 | 534 | 601 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,384 | 1,173 | 931 | 682 | 601 | 603 | 641 | 588 | 553 | 531 |
| Share Capital | 87 | 69 | 59 | 60 | 60 | 60 | 60 | 48 | 46 | 46 |
| Reserves & Surplus | 1,297 | 1,030 | 872 | 622 | 541 | 544 | 581 | 540 | 507 | 486 |
Ind Swift Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Ind Swift Laboratories income statement and profit fundamentals.
Analyze INDSWFTLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Ind Swift Laboratories share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 172 | 199 | 359 | 167 | 171 | 178 | 987 | 44 | 25 | 145 | 315 | 316 | 297 | 295 | 328 |
| Expenses | 154 | 158 | 147 | 149 | 151 | 153 | 437 | 43 | 24 | 136 | 267 | 250 | 224 | 236 | 270 |
| EBITDA | 18 | 41 | 211 | 18 | 19 | 26 | 549 | 1 | 1 | 9 | 47 | 66 | 73 | 59 | 58 |
| Operating Profit % | 9.00% | 17.00% | -7.00% | 2.00% | 1.00% | -1.00% | 17.00% | -29.00% | -99.00% | -6.00% | 12.00% | 19.00% | 23.00% | 18.00% | 12.00% |
| Depreciation | 8 | 8 | 7 | 7 | 7 | 9 | 20 | 0 | 0 | 6 | 9 | 14 | 13 | 14 | 82 |
| Interest | -2 | 1 | -27 | 1 | 2 | 1 | 3 | 0 | 0 | 10 | 22 | 20 | 21 | 21 | 24 |
| Profit Before Tax | 12 | 33 | 231 | 10 | 10 | 16 | 527 | 1 | 1 | -7 | 16 | 32 | 39 | 24 | -47 |
| Tax | -3 | 8 | 8 | 2 | 2 | 7 | 33 | 0 | 0 | -1 | 41 | 14 | 7 | 5 | 14 |
| Net Profit | 15 | 25 | 222 | 9 | 8 | 10 | 494 | 1 | 0 | -6 | -25 | 17 | 32 | 19 | -62 |
| EPS | 1.81 | 2.84 | 32.96 | 1.28 | 1.00 | 1.17 | 83.55 | 0.16 | 0.07 | -0.82 | -4.25 | 2.92 | 5.36 | 3.29 | -10.40 |
Ind Swift Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen INDSWFTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -26 | -163 | 195 | 150 | 135 | 125 | -64 | 73 | 96 | 79 |
| Investing Activities | -110 | -104 | -13 | 5 | -10 | -9 | -13 | -17 | -31 | -29 |
| Financing Activities | 69 | 699 | -186 | -141 | -124 | -133 | 100 | -62 | -69 | -48 |
| Net Cash Flow | -67 | 432 | -4 | 14 | 1 | -17 | 23 | -6 | -4 | 3 |
Ind Swift Laboratories Shareholding Pattern Screener
See Ind Swift Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Ind Swift Laboratories promoter holding and ownership changes for INDSWFTLAB on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2026-Feb | 2025-Dec | 2025-Sept | 2025-Aug | 2025-Jul | 2025-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 42.93% | 42.99% | 43.06% | 39.50% | 39.50% | 39.50% | 36.77% | 40.94% |
| FII Holding | 10.70% | 13.88% | 13.80% | 14.33% | 14.80% | 0.00% | 0.00% | 4.27% |
| DII Holding | 0.17% | 0.00% | 0.16% | 0.68% | 0.68% | 0.00% | 0.00% | 0.91% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.45% | 32.90% | 32.97% | 35.06% | 34.96% | 34.75% | 35.11% | 41.36% |
| Other Holding | 11.75% | 10.22% | 10.01% | 10.43% | 10.06% | 25.76% | 28.12% | 12.51% |
| Shareholder Count | 40,881 | 39,222 | 40,404 | 42,121 | 43,780 | 28,892 | 28,539 | 28,709 |
Ind Swift Laboratories Share Dividend Screener - Share Yield Analysis
Check Ind Swift Laboratories dividend history with payout and yield data.
View Ind Swift Laboratories dividend details including ex-dates and amounts for INDSWFTLAB stock.
Ind Swift Laboratories Stock Index Membership
See which indices include Ind Swift Laboratories stock.
Check INDSWFTLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Ind Swift Laboratories Market Events Screener - Corporate Actions
Get Ind Swift Laboratories corporate actions including splits, bonuses, and buybacks.
Check Ind Swift Laboratories stock events that may affect INDSWFTLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 4.79% |
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | 1.61% |
| 2026-08-05 | 2026-08-05 | Extraordinary General Meeting | NA | -1.94% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -0.38% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 6.32% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.70% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 1.99% |
| 2025-08-14 | 2025-08-14 | Merger - Demerger | 100:15 | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -1.61% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -4.59% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 7.84% |
| 2025-02-22 | 2025-02-22 | Extraordinary General Meeting | NA | -12.26% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -11.42% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -2.34% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -11.66% |
Ind Swift Laboratories Competitors Screener - Peer Comparison
Screen INDSWFTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Ind Swift Laboratories Company Announcements - News Screener
Screen INDSWFTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-11 | Reg. 34 (1) Annual Report. | - |
| 2026-09-11 | Notice Of 31St Annual General Meeting Scheduled To Be Held On Sept. 30 2026 | - |
| 2026-09-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-10 | Outcome Of Preferential Issue Committee Meeting Held On Friday 4Th September 2026 As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-09-02 | Board Meeting Outcome for Outcome Of Board Meeting Held On September 02 2026 | - |
| 2026-08-27 | Clarification On Movement In Volume | - |
| 2026-08-27 | Clarification sought from Ind-Swift Laboratories Ltd | - |
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-17 | Audio Recording Of Earning Conference Call Held On 17.08.2026. | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-10 | Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-10 | Statement Of NIL Deviation Or Variation Under Reg. 32 | - |
| 2026-08-10 | Board Meeting Outcome for OUTCOME OF BOARD MEETING DATED AUGUST 10 2026 | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | - |
| 2026-08-07 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |